ResearcherAbramson Cancer CenterActive in the last 2 years

Erin Elizabeth Hollander

Verified by OpenAlex author ID and NIH RePORTER profile ID (good confidence, 0.85), identity_conf@1As of 8 November 2026

Matched on OpenAlex author ID A5052814766; NIH RePORTER profile ID 15695342. Sources: OpenAlex.

Their work

Papers: 1
Trials: 0
Grants: 1
Labs led: 0
Collaborators: 4

Papers, trials and grants by year

2024: 1 grant · 2025: none · 2026: 1 paper

Papers 1

The HIF-2 transcription factor mediates resistance to ferroptosis in pancreatic cancer. Co-author DOI 10.1016/j.molcel.2026.03.007 ↗

Grants 1

Identifying the Role of Tumor Cell Intrinsic DNMT1 in Anti-Tumor Immunity in Pancreatic Ductal Adenocarcinoma F30CA260944 ↗

Closest collaborators

The 4 strongest of 4 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Alexander Muir · 1 shared paper, 2026 · strength 0.29
- Paper The HIF-2 transcription factor mediates resistance to ferroptosis in pancreatic cancer. DOI 10.1016/j.molcel.2026.03.007 ↗
Maimon E. Hubbi · 1 shared paper, 2026 · strength 0.29
- Paper The HIF-2 transcription factor mediates resistance to ferroptosis in pancreatic cancer. DOI 10.1016/j.molcel.2026.03.007 ↗
Ben Z. Stanger · 1 shared paper, 2026 · strength 0.29
- Paper The HIF-2 transcription factor mediates resistance to ferroptosis in pancreatic cancer. DOI 10.1016/j.molcel.2026.03.007 ↗
Chi Van Dang · 1 shared paper, 2026 · strength 0.29
- Paper The HIF-2 transcription factor mediates resistance to ferroptosis in pancreatic cancer. DOI 10.1016/j.molcel.2026.03.007 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.